Name (Synonyms) | Correlation | |
---|---|---|
drug755 | Lopinavir and Ritonavir Tablets Wiki | 1.00 |
drug1351 | Tap water Wiki | 1.00 |
drug95 | Arbidol Wiki | 0.71 |
drug1060 | Povidone-Iodine Wiki | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.10 |
D007239 | Infection NIH | 0.07 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx. This 4 arms interventional study compares the effect of gargling using povidone-iodine, essential oils- based, tap water with control (no intervention) among Stage 1 coronavirus disease-2019 (COVID-19) patients. Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.
Description: Swabs from oropharynx and nasopharynx will be taken at day 4 and 6 of intervention.
Measure: Early Viral Clearance Time: 6 daysDescription: Swabs from oropharynx and nasopharynx will be taken at day 12
Measure: Late viral clearance Time: 12 daysDescription: Progression will be monitored by symptoms diary for 7 days
Measure: Symptoms progression Time: 7 daysDescription: Progression will be monitored by clinical data for 14 days
Measure: Disease Progression Time: 14 daysDescription: Progression will be monitored by laboratory data for 14 days
Measure: Disease Progression 2 Time: 14 days